Clinical Trial Update: Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of capecitabine and oxaliplatin with radiation therapy for esophageal or gastroesophageal junction cancer; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Northwestern University | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-18